» Articles » PMID: 3919082

Reducing Public Expenditures for Physician Services: the Price of Paying Less

Overview
Specialty Health Services
Date 1985 Jan 1
PMID 3919082
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this paper is to examine how physicians respond to changes in payment levels from government insurers. Our analysis focuses on two issues: controlling overall program expenditures, and assuring full access to care for program clients. We review evidence from natural experiments in which payment levels were increased, frozen, or decreased. These studies show that freezing or reducing payment levels is not effective in controlling program expenditures, because physicians responded by increasing the quantity and complexity of services provided. Furthermore, when government programs freeze or reduce their payment levels, physicians are less likely to treat the clients of these programs. We conclude that policymakers must seek alternative strategies for controlling program expenditures.

Citing Articles

Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study.

Andrews C, Grogan C, Westlake M, Abraham A, Pollack H, DAunno T J Subst Abuse Treat. 2018; 87:50-55.

PMID: 29471926 PMC: 5826552. DOI: 10.1016/j.jsat.2018.01.010.


Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees.

Abraham A, Andrews C, Yingling M, Shannon J Health Serv Res. 2017; 53(1):389-404.

PMID: 28345210 PMC: 5785305. DOI: 10.1111/1475-6773.12686.


The relationship of state Medicaid coverage to Medicaid acceptance among substance abuse providers in the United States.

Andrews C J Behav Health Serv Res. 2014; 41(4):460-72.

PMID: 24407938 DOI: 10.1007/s11414-013-9387-2.


Mental health and public health: Strengthening a working relationship.

Goldstein M J Prim Prev. 2013; 10(2):99-132.

PMID: 24264625 DOI: 10.1007/BF01324968.


Impact of the Medicare Modernization Act of 2003 on utilization and spending for medicare part B-covered biologics in rheumatoid arthritis.

Doshi J, Li P, Puig A Arthritis Care Res (Hoboken). 2010; 62(3):354-61.

PMID: 20391481 PMC: 3007602. DOI: 10.1002/acr.20010.